Ozempic, a medication for type 2 diabetes and weight loss, mimics the action of GLP-1 to regulate blood sugar and appetite. Although Ozempic itself isn't found in food, high-fiber and probiotic ...

A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.

A major new study on weight-loss drugs poses a new idea for addiction treatment: small doses of Ozempic could help people cut down on drinking and smoking. For years, GLP-1 medications have been ...

Madison Burgess, a Michigan native, achieved significant weight loss with Ozempic after struggling with conventional methods. However, severe side effects led to a micro-dosing regimen ...

Dr Karan explained that ozempic is a pharmaceutical-grade, lab-engineered molecule that binds to GLP-1 receptors with laser-like precision and is designed to stay active in your system for up to a ...

When our girlfriends talk about Ozempic, body issues are the main topic in conversation. We live in a society where the pressures of “looking the part” feel like a full-time job. Ozempic is ...

A recent study has raised concerns about a potential link between semaglutide, the active ingredient in Ozempic, and a rare form of vision loss called non-arteritic anterior ischemic optic ...

The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...

As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to severe eye conditions. As the researchers note, all but one of the study ...

Novo Nordisk A/S, maker of Wegovy for obesity and Ozempic, isn’t “immune” to tariffs The European makers of Ozempic for diabetes and Cetaphil for dry skin said they would feel an impact from ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...